Antibody-mediated rejection of the cardiac allograft: Where do we stand in 2012?

Current Opinion in Organ Transplantation

Volumn 17, Issue 3, 2012, Pages 303-308

  Berry, Gerald J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antibody mediated rejection; complement deposition; grading scheme; heart transplantation and allograft; immunofluorescence; immunohistochemistry

Indexed keywords

ANTIBODY;

ANTIBODY MEDIATED REJECTION; CARDIAC GRAFT REJECTION; DISEASE CLASSIFICATION; GRAFT DYSFUNCTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LONG TERM CARE; MEDICAL SOCIETY; ORGAN DONOR; REVIEW;

GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULINS;

EID: 84861195644     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328353660f     Document Type: Review

References (29)

1. Herskowitz A, Soule LM, Ueda K, et al. Arteriolar vasculitis on endomyo-cardial biopsy: A histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients. J Heart Transplant 1987; 6:127-136. (Pubitemid 17125035)
2. Smith SH, Kirklin JK, Geer JC, et al. Arteritis in cardiac rejection after transplantation. Am J Cardiol 1987; 59:1171-1173. (Pubitemid 17077032)
3. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30:252-269.
4. Tan CD, Rodriguez ER. Diagnosis of antibody-mediated rejection in cardiac transplantation: a call for standardization. Curr Opin Organ Transplant 2010; 15:769-773.
5. Kfoury AG, Hammond ME. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant 2010; 29:389-394.
6. Taylor DO, Yowell RL, Kfoury AG, et al. Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immuno-histopathologic pattern of vascular rejection. J Heart Lung Transplant 2000; 19:518-521. (Pubitemid 30387056)
7. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22:58-69. (Pubitemid 36071418)
8. Casarez TW, Perens G, Willias RJ, et al. Humoral rejection in pediatric orthotopic heart transplantation. J heart Lung Transplantation 2007; 26: 114-119. (Pubitemid 46136037)
9. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28:417-422.
10. Kfoury AG, Hammond ME, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant 2009; 28:781-784.
11. Kfoury AG, Snow GL, Budge D, et al. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplantation 2012; 31:46-51.
12. Berry G, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30:601-611.
13. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989; 8:430-443. (Pubitemid 20044096)
14. Billingham ME, Vary NR, Hammond EH, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9:587-593.
15. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720. (Pubitemid 41641841)
16. Reed EF, DeMetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25:153-159. (Pubitemid 43156365)
17. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Transplantation 2004; 4:1033-1041. (Pubitemid 38868592)
18. Kobashigawa J, Mehra M, West, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28:213-225.
19. Bayliss J, Bailey M, Leet A, et al. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation 2008; 86:991-997.
20. Loupy A, Cazes A, Guillemain R, et al. Very late transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 2011; 11:1478-1487.
21. Hodges AM, Lyster H, McDermott A, et al. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibodies. Transplantation 2012: [Epub ahead of print].
22. Kucirka LM, Maleszewsli JJ, Segev DL, Halushka MK. Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Cardiovasc Pathol 2011; 20:132-138.
23. Burke M, AndersenC, Ashworth M, etal. C4d methodology and interpretation in biopsy diagnosis of cardiac antibody-mediated rejection: A European survey from the Transplant Working Group of the Association for European Cardiovascular Pathology (AECVP). J Heart Lung Transplant 2010; 29:S37-S38.
24. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10:464-471.
25. Fedrigo M, Gambino A, Benazzi E, et al. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30:1381-1388.
26. Hammond ME, Stehlik J, Snow et al. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies. J Heart Lung Transplant 2005; 24:2015-2021. (Pubitemid 41814718)
27. Tavora F, Munivenkatappa R, Papadimitriou J, et al. Endotheliitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection. J Heart Lung Transplant 2011; 30:435-444.
28. Revelo MP, Stehlik J, Miller D, et al. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart transplant 2011; 30:144-150.
29. Tan CD, Sokos GG, Pidwell DJ, et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009; 9:2075-2084.